William Blair Brokers Increase Earnings Estimates for DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) – Equities research analysts at William Blair boosted their Q2 2023 EPS estimates for DENTSPLY SIRONA in a report issued on Wednesday, May 3rd. William Blair analyst B. Vazquez now forecasts that the medical instruments supplier will post earnings of $0.43 per share for the quarter, up from their previous forecast of $0.41. William Blair has a “Market Perform” rating on the stock. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.91 per share. William Blair also issued estimates for DENTSPLY SIRONA’s FY2023 earnings at $1.92 EPS.

A number of other brokerages also recently issued reports on XRAY. Robert W. Baird boosted their price target on DENTSPLY SIRONA from $36.00 to $46.00 in a report on Thursday. Piper Sandler upped their target price on DENTSPLY SIRONA from $29.00 to $35.00 and gave the company a “neutral” rating in a report on Monday, February 6th. Morgan Stanley lifted their price target on shares of DENTSPLY SIRONA from $39.00 to $45.00 and gave the company an “overweight” rating in a report on Wednesday, April 19th. The Goldman Sachs Group upped their price objective on shares of DENTSPLY SIRONA from $34.00 to $39.00 and gave the stock a “neutral” rating in a report on Wednesday, March 1st. Finally, TheStreet upgraded shares of DENTSPLY SIRONA from a “d+” rating to a “c” rating in a research report on Tuesday, February 28th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $42.13.

DENTSPLY SIRONA Stock Up 1.1 %

Shares of NASDAQ XRAY opened at $41.30 on Monday. The company has a market cap of $8.78 billion, a price-to-earnings ratio of 15.30, a PEG ratio of 2.36 and a beta of 0.91. The company has a quick ratio of 1.08, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The firm’s fifty day moving average is $39.14 and its 200 day moving average is $35.09. DENTSPLY SIRONA has a 52 week low of $26.48 and a 52 week high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last issued its earnings results on Wednesday, May 3rd. The medical instruments supplier reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.05. DENTSPLY SIRONA had a positive return on equity of 8.65% and a negative net margin of 26.41%. The company had revenue of $978.00 million during the quarter, compared to analysts’ expectations of $938.16 million. During the same period in the prior year, the business posted $0.52 EPS. DENTSPLY SIRONA’s quarterly revenue was up .9% compared to the same quarter last year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 14th. Stockholders of record on Friday, March 31st were paid a $0.125 dividend. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.21%. The ex-dividend date of this dividend was Thursday, March 30th.

Insider Buying and Selling

In related news, Director Eric Brandt sold 6,200 shares of DENTSPLY SIRONA stock in a transaction that occurred on Tuesday, May 2nd. The stock was sold at an average price of $42.17, for a total transaction of $261,454.00. Following the sale, the director now owns 44,902 shares of the company’s stock, valued at approximately $1,893,517.34. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, SVP Cord Friedrich Staehler sold 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 7th. The stock was sold at an average price of $39.33, for a total transaction of $157,320.00. Following the sale, the senior vice president now directly owns 97,693 shares of the company’s stock, valued at approximately $3,842,265.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Eric Brandt sold 6,200 shares of the firm’s stock in a transaction on Tuesday, May 2nd. The shares were sold at an average price of $42.17, for a total transaction of $261,454.00. Following the completion of the transaction, the director now directly owns 44,902 shares of the company’s stock, valued at $1,893,517.34. The disclosure for this sale can be found here. 0.74% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. grew its position in DENTSPLY SIRONA by 1.2% in the third quarter. Vanguard Group Inc. now owns 24,732,513 shares of the medical instruments supplier’s stock worth $701,167,000 after acquiring an additional 297,487 shares in the last quarter. Artisan Partners Limited Partnership lifted its position in DENTSPLY SIRONA by 2.7% in the fourth quarter. Artisan Partners Limited Partnership now owns 13,582,284 shares of the medical instruments supplier’s stock worth $432,460,000 after buying an additional 352,358 shares during the last quarter. Nuance Investments LLC boosted its stake in DENTSPLY SIRONA by 0.7% during the fourth quarter. Nuance Investments LLC now owns 12,642,319 shares of the medical instruments supplier’s stock worth $402,531,000 after buying an additional 92,591 shares during the period. First Eagle Investment Management LLC raised its stake in shares of DENTSPLY SIRONA by 3.3% in the fourth quarter. First Eagle Investment Management LLC now owns 9,744,258 shares of the medical instruments supplier’s stock valued at $310,257,000 after acquiring an additional 311,585 shares during the period. Finally, Morgan Stanley lifted its holdings in shares of DENTSPLY SIRONA by 2.4% in the 4th quarter. Morgan Stanley now owns 8,692,375 shares of the medical instruments supplier’s stock worth $276,765,000 after acquiring an additional 205,096 shares during the last quarter. Institutional investors own 98.52% of the company’s stock.

DENTSPLY SIRONA Company Profile

(Get Rating)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.